HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana-Maria Dancau Selected Research

Trastuzumab (Herceptin)

7/2010Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma.
6/2009HER-2 amplification is highly homogenous in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana-Maria Dancau Research Topics

Disease

3Neoplasms (Cancer)
09/2010 - 06/2009
2Adenocarcinoma
09/2010 - 06/2009
2Lymphatic Metastasis
07/2010 - 06/2009
1Esophageal Neoplasms (Esophageal Cancer)
07/2010
1Carcinoma (Carcinomatosis)
07/2010
1Stomach Neoplasms (Stomach Cancer)
06/2009
1Breast Neoplasms (Breast Cancer)
06/2009

Drug/Important Bio-Agent (IBA)

2Trastuzumab (Herceptin)FDA Link
07/2010 - 06/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2010
1ErbB Receptors (EGF Receptor)IBA
09/2010
1Cetuximab (Erbitux)FDA Link
09/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2010
1human ERBB2 proteinIBA
07/2010
1Indicators and Reagents (Reagents)IBA
06/2009

Therapy/Procedure

3Therapeutics
09/2010 - 06/2009